MeSH tree: E01.370.350
Obsessive-compulsive disorder (OCD) can be an extremely incapacitating neuropsychiatric condition. The symptoms of people who suffer from OCD can entail washing their hands or showering over and over again, repeatedly checking ...
Jul 7, 2026
0
4
One of the uncomfortable truths about multiple sclerosis is that the part of the brain likely to reveal the most about the disease and how a patient will be affected has been mostly invisible to clinicians.
Jul 7, 2026
0
67
A study conducted by the Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau has identified for the first time in living individuals a brain pattern related to the tau protein that changes according to the ...
Jul 6, 2026
0
7
New research has found that digital breast tomosynthesis (DBT) availability at breast imaging facilities is similar across low- and high-deprivation areas, but facilities in low-deprivation areas are significantly more likely ...
Jul 2, 2026
0
6
More than half the calories consumed by young kids in the U.S. come from ultra-processed foods.
Jul 2, 2026
0
8
For people at high risk of developing breast cancer, yearly mammograms may not be enough to detect tumors early. To make earlier diagnosis easier, an MIT team has developed portable detectors based on ultrasound, which could ...
Jul 1, 2026
0
9
For decades, neuroscientists have known that specific regions in the brain's left hemisphere are responsible for processing language. However, a new study by MIT researchers shows that language processing also occurs in many ...
Jul 1, 2026
0
15
A University of Queensland study has found that patient access to one of the most exciting frontiers in cancer treatment is being stalled because health systems struggle to accurately assess its cost-effectiveness. The study, ...
Jul 1, 2026
0
3
Periodontal (gum) disease is one of the most prevalent diseases worldwide, caused by the bacterium Porphyromonas gingivalis (P. gingivalis). In Japan alone, approximately 80% of adults 30 and older are affected or considered ...
Jun 30, 2026
0
7
Canada recently approved lecanemab to treat early Alzheimer's disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex. An article in the Canadian Medical Association ...
Jun 29, 2026
0
7
